Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 10.40
+0.10 (0.97%)
Apr 1, 2026, 12:02 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 799.76 million as of April 2, 2026. Its market cap has increased by 120.23% in one year.
Market Cap
799.76M
Enterprise Value
729.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.40
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has increased from 720.55M to 799.76M, an increase of 10.99%. That is a compound annual growth rate of 2.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 799.76M | 18.58% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.32B |
| Thor Medical ASA | 1.77B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 493.35M |
| SoftOx Solutions AS | 275.20M |
| Oncoinvent ASA | 209.23M |
| Aqua Bio Technology ASA | 106.39M |